-
Aurobindo Pharma Stock Gains Over 1.5% to Rs 1,470 After FTC Conditionally Clears $250 Million Lannett Acquisition; Must Divest 4 Generic Products to Quagen Pharma
- June 19, 2026
- Posted by: Ankit Jaiswal
- Category: News
No Comments
Aurobindo Pharma hits Rs 1,470 day high (+1.82%) on June 19 after FTC clears $250M Lannett deal. Must divest 4 generic products to Quagen Pharma. Indiana facility and ADHD entry intact. FY27 $2B US target.
-
Varun Beverages Stock Gains on Asahi Group Partnership to Launch CALPIS Brand in India; PepsiCo Franchise Now Extended to 2049
- June 18, 2026
- Posted by: Ankit Jaiswal
- Category: News
Varun Beverages stock opens +1.4% on 18 June 2026 on Asahi Group CALPIS India deal but pares gains. CALPIS is a Japanese dairy soft drink. PepsiCo bottling deal extended to April 2049. Full analysis.